SUCCIPRO

SUCCIPRO

Investigación biotecnológica

A spin-off company developing first-in class succinate-modulating therapies for inflammatory and metabolic disorders

Sobre nosotros

We are a spin-off company from Pere Virgili Health Research institute (IISPV) and Rovira Virgili University. We are expert in succinate and are developing first-in-class molecules able to modulate succinate, a metabolite with pro-inflammatory properties that is increased in many metabolic and inflammatory disorders. The company has a diversified pipeline of candidates at an early preclinical phase and is working with several clinical indicacions, which include Type 2 Diabetes, obesity, Inflammatory bowel Disease and Non-Alcoholic Steatohepatitis

Sitio web
www.succipro.com
Sector
Investigación biotecnológica
Tamaño de la empresa
De 2 a 10 empleados
Sede
Tarragona
Tipo
De financiación privada
Fundación
2022

Ubicaciones

Empleados en SUCCIPRO

Actualizaciones

Páginas similares